Topics:

Natural History of HIV Supports the Use Of Early Interventions

Natural History of HIV Supports the Use Of Early Interventions

NEW YORK--The more that is learned about the natural history of
the human immunodeficiency virus (HIV), the stronger the case
for early intervention. Recent research confirms "the notion
that HIV infection is a dynamic process throughout the course
of infection," said H. Clifford Lane, MD, clinical director,
National Institute of Allergy and Infectious Diseases (NIAID).

Speaking at a CME program on the management of HIV-infected patients,
jointly sponsored by the Center for Bio-Medical Communication
and AmFAR (American Foundation for AIDS Research), Dr. Lane said
that the dynamic balance between viral burden and CD4+ T cell
levels remains the primary indicator of the progress of the disease
(see box).

Within 3 to 6 weeks of primary infection, levels of virus are
observed to peak and then begin to decline. It is hypothesized
that this indicates the beginning of an immune response.

"The strength of the immune response at this critical juncture
seems to have a long-lasting impact on the patient," he said.
Patients who are able to control the virus, as evidenced by low
levels of HIV RNA and diverse T-cell immune response, do much
better than those whose response is more restricted and whose
levels of HIV RNA are higher.

Clinically, those patients with the most severe symptoms tend
to be the ones who show the highest propensity for rapid progression,
he said.

Nonetheless, the majority of patients eventually experience a
decline in CD4+ T cell count and an increase in viralburden, resulting
in disease progression. It now appears that so-called long-term
nonprogressors are merely part of a continuum, Dr. Lane commented.

He said that certain qualitative changes in the immune system
have profound implications for therapeutic intervention and underline
the importance of intervening at the earliest possible moment.

Pages

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.